DNA-catalyzed polymerization.
J Am Chem Soc.
2002 Feb 6;124(5):746-7. doi: 10.1021/ja017319j. PubMed PMID:
11817938.
The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis.
Pharmacol Rev.
2015;67(1):103-17. doi: 10.1124/pr.114.009381. Review. PubMed PMID:
25395505; PubMed Central PMCID:
PMC4279074.
Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis.
FASEB J.
2016 Jun;30(6):2435-50. doi: 10.1096/fj.201500197R. Epub 2016 Mar 22. PubMed PMID:
27006447; PubMed Central PMCID:
PMC4871797.
ADAM10-mediated ephrin-B2 shedding promotes myofibroblast activation and organ fibrosis.
Nat Med.
2017 Dec;23(12):1405-1415. doi: 10.1038/nm.4419. Epub 2017 Oct 23. PubMed PMID:
29058717; PubMed Central PMCID:
PMC5720906.
The Rho Kinase Isoforms ROCK1 and ROCK2 Each Contribute to the Development of Experimental Pulmonary Fibrosis.
Am J Respir Cell Mol Biol.
2018 Apr;58(4):471-481. doi: 10.1165/rcmb.2017-0075OC. PubMed PMID:
29211497; PubMed Central PMCID:
PMC5894496.
Peroxidase Sensitive Amplifiable Probe for Molecular Magnetic Resonance Imaging of Pulmonary Inflammation.
ACS Sens.
2019 Sep 27;4(9):2412-2419. doi: 10.1021/acssensors.9b01010. Epub 2019 Aug 22. PubMed PMID:
31397156; PubMed Central PMCID:
PMC6924005.
Vascular permeability in the fibrotic lung.
Eur Respir J.
2020 Jul;56(1). doi: 10.1183/13993003.00100-2019. Print 2020 Jul. PubMed PMID:
32265308; PubMed Central PMCID:
PMC9977144.
Existing Crisis Standards of Care Triage Protocols May Not Significantly Differentiate Between Patients With Coronavirus Disease 2019 Who Require Intensive Care.
Crit Care Explor.
2021 Apr;3(4):e0412. doi: 10.1097/CCE.0000000000000412. eCollection 2021 Apr. PubMed PMID:
33928259; PubMed Central PMCID:
PMC8078457.
Exercise performance in patients with post-acute sequelae of SARS-CoV-2 infection compared to patients with unexplained dyspnea.
EClinicalMedicine.
2021 Sep;39:101066. doi: 10.1016/j.eclinm.2021.101066. eCollection 2021 Sep. PubMed PMID:
34476393; PubMed Central PMCID:
PMC8401400.
Endothelial-Specific Loss of Sphingosine-1-Phosphate Receptor 1 Increases Vascular Permeability and Exacerbates Bleomycin-induced Pulmonary Fibrosis.
Am J Respir Cell Mol Biol.
2022 Jan;66(1):38-52. doi: 10.1165/rcmb.2020-0408OC. PubMed PMID:
34343038; PubMed Central PMCID:
PMC8803357.
Case 15-2022: A 57-Year-Old Man with Persistent Cough and Pulmonary Opacities.
N Engl J Med.
2022 May 19;386(20):1933-1944. doi: 10.1056/NEJMcpc2201234. PubMed PMID:
35584159.
Screening for Inhibitors of YAP Nuclear Localization Identifies Aurora Kinase A as a Modulator of Lung Fibrosis.
Am J Respir Cell Mol Biol.
2022 Jul;67(1):36-49. doi: 10.1165/rcmb.2021-0428OC. PubMed PMID:
35377835; PubMed Central PMCID:
PMC9798384.
Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse model.
Proc Natl Acad Sci U S A.
2022 Jul 12;119(28):e2204174119. doi: 10.1073/pnas.2204174119. Epub 2022 Jul 5. PubMed PMID:
35787042; PubMed Central PMCID:
PMC9282378.
The Vasculature in Pulmonary Fibrosis.
Curr Tissue Microenviron Rep.
2022 Dec;3(4):83-97. doi: 10.1007/s43152-022-00040-9. Epub 2022 Jul 13. PubMed PMID:
36712832; PubMed Central PMCID:
PMC9881604.
Myofibroblast-specific inhibition of the Rho kinase-MRTF-SRF pathway using nanotechnology for the prevention of pulmonary fibrosis.
Am J Physiol Lung Cell Mol Physiol.
2023 Feb 1;324(2):L190-L198. doi: 10.1152/ajplung.00086.2022. Epub 2023 Jan 10. PubMed PMID:
36625494; PubMed Central PMCID:
PMC9925159.
Tailored chemical reactivity probes for systemic imaging of aldehydes in fibroproliferative diseases.
bioRxiv.
2023 Apr 21;. doi: 10.1101/2023.04.20.537707. PubMed PMID:
37131719; PubMed Central PMCID:
PMC10153247.
Vascular BMPRs Strike Out the Rolling Ball of Fibrosis.
Am J Respir Crit Care Med.
2023 Jun 1;207(11):1419-1421. doi: 10.1164/rccm.202303-0382ED. PubMed PMID:
36952237; PubMed Central PMCID:
PMC10263134.
Tailored Chemical Reactivity Probes for Systemic Imaging of Aldehydes in Fibroproliferative Diseases.
J Am Chem Soc.
2023 Sep 27;145(38):20825-20836. doi: 10.1021/jacs.3c04964. Epub 2023 Aug 17. PubMed PMID:
37589185; PubMed Central PMCID:
PMC11022681.
Optimization of an Allysine-Targeted PET Probe for Quantifying Fibrogenesis in a Mouse Model of Pulmonary Fibrosis.
Mol Imaging Biol.
2023 Oct;25(5):944-953. doi: 10.1007/s11307-023-01845-2. Epub 2023 Aug 23. PubMed PMID:
37610609.
Alveolar Vascular Remodeling in Nonspecific Interstitial Pneumonia: Replacement of Normal Lung Capillaries with COL15A1-Positive Endothelial Cells.
Am J Respir Crit Care Med.
2023 Oct 1;208(7):819-822. doi: 10.1164/rccm.202303-0544LE. PubMed PMID:
37552025; PubMed Central PMCID:
PMC10563189.
Integrated Immunopeptidomic and Proteomic Analysis of COVID-19 lung biopsies.
Front Immunol.
2023;14:1269335. doi: 10.3389/fimmu.2023.1269335. eCollection 2023. PubMed PMID:
37942334; PubMed Central PMCID:
PMC10628763.
Activation of CD8(+) T Cells in Chronic Obstructive Pulmonary Disease Lung.
Am J Respir Crit Care Med.
2023 Dec 1;208(11):1177-1195. doi: 10.1164/rccm.202305-0924OC. PubMed PMID:
37756440; PubMed Central PMCID:
PMC10868372.
Augmentation of Endothelial S1PR1 Attenuates Postviral Pulmonary Fibrosis.
Am J Respir Cell Mol Biol.
2024 Feb;70(2):119-128. doi: 10.1165/rcmb.2023-0286OC. PubMed PMID:
37934676; PubMed Central PMCID:
PMC10848698.
Lactate transport inhibition therapeutically reprograms fibroblast metabolism in experimental pulmonary fibrosis.
bioRxiv.
2024 Apr 28;. doi: 10.1101/2024.04.25.591150. PubMed PMID:
38712233; PubMed Central PMCID:
PMC11071479.
Paving the ROCKy Path to Novel Antifibrotics.
Am J Respir Cell Mol Biol.
2024 Oct;71(4):381-382. doi: 10.1165/rcmb.2024-0224ED. PubMed PMID:
38864857; PubMed Central PMCID:
PMC11450308.
Leukemia inhibitory factor (LIF) receptor amplifies pathogenic activation of fibroblasts in lung fibrosis.
Proc Natl Acad Sci U S A.
2024 Dec 10;121(50):e2401899121. doi: 10.1073/pnas.2401899121. Epub 2024 Dec 5. PubMed PMID:
39636853; PubMed Central PMCID:
PMC11648669.
Endothelial ActRIIA inhibition protects the cardiac microvasculature in severe viral respiratory infection.
Res Sq.
2025 Apr 1;. doi: 10.21203/rs.3.rs-6306417/v1. PubMed PMID:
40235477; PubMed Central PMCID:
PMC11998776.
Ectopic Expansion of Pulmonary Vasculature in Fibrotic Lung Disease and Lung Adenocarcinoma Marked by Proangiogenic COL15A1+ Endothelial Cells.
Pulm Circ.
2025 Apr;15(2):e70102. doi: 10.1002/pul2.70102. eCollection 2025 Apr. PubMed PMID:
40463493; PubMed Central PMCID:
PMC12130637.
Opportunity knocks: the fourth cohort of the American Journal of Physiology-Lung Cellular and Molecular Physiology Early Career Editorial Fellowship Program.
Am J Physiol Lung Cell Mol Physiol.
2025 Sep 1;329(3):L324-L326. doi: 10.1152/ajplung.00238.2025. Epub 2025 Jul 23. PubMed PMID:
40701621.
Peeling Back the Layers of the Bleomycin Model of Lung Fibrosis: Lessons Learned, Factors to Consider, and Future Directions.
Semin Respir Crit Care Med.
2025 Aug;46(4):330-346. doi: 10.1055/a-2649-9402. Epub 2025 Aug 13. Review. PubMed PMID:
40803339.
Hydrogel nanocomposite-based breathable non-adhesive coating for oxygen sensing film used within extracorporeal perfusion system.
Sci Rep.
2025 Nov 5;15(1):38734. doi: 10.1038/s41598-025-22520-2. PubMed PMID:
41193620; PubMed Central PMCID:
PMC12589492.
Pharmacological profile and therapeutic evaluation of ROC-101, a potent and selective ROCK inhibitor, in arterial hypertension and pulmonary fibrosis.
Pharmacol Res.
2026 Jan;223:108062. doi: 10.1016/j.phrs.2025.108062. Epub 2025 Dec 8. PubMed PMID:
41371481.
Nanotherapeutic strategies for fibroblast targeted treatment of pulmonary fibrosis.
Nanomedicine (Lond).
2026 Mar;21(5):643-646. doi: 10.1080/17435889.2025.2603167. Epub 2025 Dec 17. PubMed PMID:
41404989; PubMed Central PMCID:
PMC12964902.
Spatial transcriptomics reveals altered communities and drivers of aberrant epithelia and pro-fibrotic fibroblasts in interstitial lung diseases.
Cell Genom.
2026 Mar 11;6(3):101066. doi: 10.1016/j.xgen.2025.101066. Epub 2026 Jan 22. PubMed PMID:
41576947; PubMed Central PMCID:
PMC12985369.
Artificial intelligence, machine learning-based automated fibrosis quantification in preclinical models of pulmonary fibrosis.
Respir Res.
2026 Feb 4;27(1). doi: 10.1186/s12931-026-03536-2. PubMed PMID:
41639734; PubMed Central PMCID:
PMC12961772.
Regulation of basal and tumour necrosis factor α-induced fibroblast gene expression by peptidylarginine deiminase 2.
J Physiol.
2026 Mar 15;. doi: 10.1113/JP290391. [Epub ahead of print] PubMed PMID:
41832613; PubMed Central PMCID:
PMC12991426.
Enhancing the antifibrotic potential of the endothelium: lipid nanoparticles to the rescue.
Am J Respir Cell Mol Biol.
2026 Apr 1;74(4):419-420. doi: 10.1165/rcmb.2025-0563ED. PubMed PMID:
41092093.
Lactate transport inhibition therapeutically reprograms fibroblast metabolism in experimental pulmonary fibrosis.
Sci Transl Med.
2026 May 6;18(848):eads2673. doi: 10.1126/scitranslmed.ads2673. Epub 2026 May 6. PubMed PMID:
42090478.
What would you like to do?